key: cord-1040935-k65k8j2c authors: Chhetri, Abhijit; Chettri, Sailesh; Rai, Pranesh; Mishra, Dipu Kumar; Sinha, Biswajit; Brahman, Dhiraj title: Synthesis, Characterization and Computational Study on Potential Inhibitory Action of Novel Azo Imidazole Derivatives against COVID-19 Main Protease (M(pro): 6LU7) date: 2020-09-18 journal: J Mol Struct DOI: 10.1016/j.molstruc.2020.129230 sha: 2c8e6cc231d9b20949ed117bd60b2f48c36749fb doc_id: 1040935 cord_uid: k65k8j2c A series of six novel imidazole anchored azo-imidazole derivatives (L1-L6) have been prepared by the simple condensation reaction of azo-coupled ortho-vaniline precursor with amino functionalised imidazole derivative and the synthesized derivatives (L1-L6) have been characterized by different analytical and spectroscopic techniques. Molecular docking studies were carried out to ascertain the inhibitory action of studied ligands (L1-L6) against the Main Protease (6LU7) of novel coronavirus (COVID-19). The result of the docking of L1-L6 showed a significant inhibitory action against the Main protease (M(pro)) of SARS-CoV-2 and the binding energy (ΔG) values of the ligands (L1-L6) against the protein 6LU7 have found to be -7.7 Kcal/mole (L1), -7.4 Kcal/mole (L2), -6.7 Kcal/mole (L3), -7.9 Kcal/mole (L4), -8.1 Kcal/mole (L5) and -7.9 Kcal/mole (L6). Pharmacokinetic properties (ADME) of the ligands (L1-L6) have also been studied. Severe acute respiratory syndrome-2 (SARS-CoV-2) or COVID-19, a novel pathogen belonging to a class of large and diverse family of enveloped, positive RNA viruses outbreak in Wuhan city of China in late December 2019 and by the beginning of the year 2020, it has became one of the most debilitating and lethal viral respiratory disease which attack the respiratory tract, causing difficulties in breathing, cough, high fever, sore throat, diarrhea, effects gastrointestinal system, heart, kidney and central nervous system leading to multiple organ failure and ultimately even death as similar to the infection caused by SARS-CoV and MERS-CoV [1] [2] [3] . By the end of February 2020 and beginning of the March 2020, the SARS-CoV-2 infection disease spread almost in every country around the world and World Health Organization (WHO) on March 11 th 2020 declared SARS-CoV-2 disease as pandemic [4] . As of June 17 th 2020, more than 8.4 million people were infected and nearly 0.45 million people have succumbed to the SARS-CoV-2 epidemic (worldometer, June 17 th 2020). Recent studies on SARS-CoV-2 have shown that the genome of SARS-CoV-2 is over 80% similar to previously reported SARS-CoV and spike protein receptor binding domain (RBD) and its host receptor (ACE2) similar to that of SARS-CoV is mainly responsible for cross species and human to human transmission of SARS-CoV-2 virus [5] [6] [7] [8] . As of now, no potential and specific therapeutic agents or vaccine is approved or available [9] . Many researchers and scientists around the world are engaged in developing specific and potential antiviral drug or vaccine to treat the SARS-CoV-2 infection [10] [11] . However, only a supportive measures in terms of FDA approved antiviral, antimalarila drugs and therapeutic agents such as remdesivir, hydroxychloroquine, chloroquine, lopinavir, umifenovir, favipiravir, and oseltamivir and Ascorbic acid, Azithromycin, Corticosteroids, Nitric oxide, IL-6 antagonists as a clinical management are available for the treatment of SARS-CoV-2 disease till date [12] . Many research studies on viruses such as HIV virus, Hepatitis C virus and Ebola virus have shown that the viral protease is the common target for the development of antiviral drugs [13] [14] [15] . Since, the main protease (Mpro) or 3CLPro) of coronavirus is conserved among the coronaviruses and it is mainly responsible for the viral replication [16] [17] . Thus, any inhibitors which inhibit the main protease (3CLpro or M pro ) and block the replication of SARS-CoV-2 would be effective and specific measures for the development of therapeutic agents or antiviral drugs against SARS-CoV-2 [18] . Again, it is well known that the development and discovery of new therapeutic agents or drugs by traditional methods is time consuming, costly and rigorous scientific in-vivo and in-vitro processes and therefore, to supplement the old traditional method, now a day, computer aided in silico techniques are gaining lot of importance for the designing and formulation of new therapeutic agents or drugs [19] [20] . On the other hand, among the various nitrogen containing heterocyclic compounds, imidazole ring are ubiquitous in natural products and possess unique structural features with wide spectrum of biological activities [21] . Thus, unique structural features and electron rich property of imidazole ring have been exploited by pharmaceutical industries for designing, formulating and development of imidazole based therapeutic agents in the wide spectrum of medicinal filed such as anticancer, anti HIV, antimicrobial, anticonvulsant, antihypertensive, analgesic, anti-inflammatory, antidepressant, analgesic, antileishmanial, anticonvulsant, anti-inflammatory etc [22] [23] [24] . Again, natural diazo (-N=N-) alkaloid compounds are found in many microorganism, marine organisms, plant parts, fungi and ascomycetes and diazo compounds by virtue of possessing diverse biological activities have been used in various fields such as antiviral, antibacterial, antifungal, antitumor, hypotensive and anti-inflammatory therapeutic agents [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] . Some of the azo compounds have found to posses excellent inhibitory potential towards HIV-1 protein ( fig. 1 ) [40] . Moreover, prontosil, an antibacterial drug and phenazopyridine, local analgesic effects on urinary tract infection are FDA approved drugs which contain azo linkage [41] [42] [43] . Chemical structures of some naturally occurring azo alkaloid compounds and FDA approved drugs are depicted in fig. 1 . Thus, incorporation of imidazole ring and diazo (N=N) moiety in a single molecule could result in formulation of compounds with interesting properties and diverse biological activities. Therefore, in continuation to our research work in the field of synthesis of azo imidazole derivatives, herein, we report the synthesis of six novel azo imidazole derivatives and an attempt has been made to carry out computational study on inhibitory potential of these novel azo imidazole derivatives against the main protease ((M pro : 6LU7) of SARS-CoV-2. Analytical grade solvents and reagents (Sd fine chemical company India and Sigma Aldrich) were used without further purification for the synthesis of azo imidazole derivatives. The azo aldehyde precursors and amino functionalized imidazole were prepared by following the literature procedure [44] [45] [46] [47] . The IR spectra of the synthesized compounds were measured using Perkin-Elmer Spectrum FT-IR spectrometer (RX-1) in KBr pellets. 1 H-NMR spectra (chemical shift values are quoted in δ ppm) were recorded at room temperature on Bruker Advance-II NMR Spectrometer operating at 400 MHz magnetic field in DMSO-d 6 solvent with reference to tetramethylsilane (TMS) as an internal standard. Elemental microanalyses (C, H and N) were measured in Perkin-Elmer (Model 240C) analyzer. The purity of the prepared compounds was checked by thin layer chromatography (TLC) on silica gel plates coated in aluminum sheets (silica gel 60 F254). The X-ray crystallographic structure of main protease (M por , PDB ID 6LU7) of SARS-CoV-2 has been downloaded from the Protein Data Bank (PDB) (http: //www.pdb.org.) database. Preparation of protein for docking simulation was achieved by using Graphical User Interface program "Auto Dock Tools (ADT) 1.5.6" (Molecular Graphics Laboratory tool or MGL tool) developed by Scripps Research Institute [48] . Specific chain (Chain A) of the protein (6LU7) has been selected for the preparation of receptor protein input file for docking study. Receptor protein preparation for docking study was initiated by removing water molecules, hetero atoms and co-crystallised ligands from PDB crystal structure of protein 6LU7, polar hydrogen atoms along with Kollman united atom charges were added subsequently to the receptor protein and finally the receptor protein input file was saved as .pdbqt file [49] [50] [51] . [53] [54] . In order to eliminate any biasness arising during the docking study, blind docking of ligand into the protein were carried out by constructing three dimensional (3D) affinity (grid) maps and electrostatic grid boxes of dimension 50×50×50 Å grid points and grid centre (X, Y, Z) of -26.283 12.599 58.966 with a spacing of 1.00 Å with the help of AutoGrid auxiliary program for each of the receptor to cover the entire active site and essential residues within the binding pocket [55] . Lamarckian genetic algorithm was used for all docking simulation and all the torsions were allowed to rotate. The predicted inhibitory constant (pK i ) was estimated using the following standardized equation [56] . [64] . In the FT-IR spectra of the compound L5, a band at 1702 cm -1 can be assigned to the carbonyl stretching frequency of COOH group [65] . A few spectra of the representative compounds (L1 and L5) are depicted in Fig.3 and 4 . A strong band in the range 836-847 cm -1 can be attributed for stretching vibration of PF 6 group [59] . Thus the IR spectral data therefore supports the formation of the compounds (L1-L6) and the infrared spectra of other compounds (L2, L3, L4 and L6) are given in supplementary file (Fig S1-Fig S4) . The validation of the proposed structure of synthesized product can be achieved by closely analysing FT-NMR spectra of the synthesized azo imidazole derivatives L1-L6. Fig S5 -Fig S6) . Prior to clinical and animal studies, any substance or compound to be categorized as drug candidate, the pharmacokinetic properties like absorption, distribution, metabolism, excretion and toxicity (ADMET) of the candidate compound are fundamental parameters as it determines the drug likeness as well as activity inside the body of the studied compound [67] . with proton (H) of OH group at a distance 2.98Å respectively (Fig. 8) . The amino acid residue His163, Met165 and His 172 interacts with the ligand L1 through π-alkyl (π electron of amino acid residues and OCH 3 group of L1) interactions. Apart from these interactions, πdonor hydrogen bonds are formed by the residues Thr24, Thr26, Phe140 and Cys145. Some van der walls interactions between the residues Thr25, Leu27, Thr45, Met49, Asn142, Glu160, Gln189 and Thr190 and L1 has been observed. Also an unfavorable acceptor acceptor interaction has been observed between the ligand and the residue Leu141. Analysis of docking result of ligand L2 with protein 6LU7 revealed that the ligand binds with the protein at the interface between domain II and domain III with binding energy -7.4 Kcal/mole and predicted inhibitory constant 2.89µM. A close inspection of the docking result showed that the ligand L2 binds with the protein with three favorable hydrogen bonding interactions. The hydrogen bonds are formed between, NH 2 group of amino acid residue Gln110 and N atom of azomethine group (C=N) of L2 at a distance 2.50Å, NH 2 group of amino acid residue Asn151 and NO 2 group of L2 at a distance 1.95Å and OH group of residue Ser158 and NO 2 group of L2 at a distance 3.08Å respectively (Fig. S7) . Amino acid residue Phe294 found to interact through π-π stacking interactions between the π-electron of Phe294 and π-electron of L2 at a distance 4.26Å. The other types of interactions such as π-σ (Ile106 and NO 2 group of L2) interaction, π-alkyl (Phe8, Val104 and OCH 3 group of L2) interaction and Van der walls (residues Gln107, Thr111, Asp153, Cys160, Val202, His246, Ile249, Thr292 and Pro293) interactions are found to exist between ligand L2 and protein 6LU7. Result obtained by docking of L3 with protein 6LU7 revealed that the ligand L3 fits inside respectively. The S atom of amino acid residue Met165 forms π-sulpher interaction with π electron of L3 at a distance 5.07Å (Fig.S8) (Fig. S9) . Also, the π electron of residues His163 and His172 forms π-alkyl interaction with OCH 3 group of L4. Apart from these interactions, other interactions such as π-donor H bond between the residues Thr24 and Thr26 and ligand L4 and Van der walls interactions between the ligand L4 and residues Thr25, Leu27, Thr45, Met49, Phe140, Asn142, Gly143, Ser144, Met165, Glu166, Pro168 and Thr190 also exist. (Fig. S10 ). S atom of amino acid residue Met165 form πsulpher interactions with π electron of ligand L6 at a distance 5.60Å. Apart from these interactions, other interactions such as π-alkyl (between π electron of residue His163 and His172 and OCH 3 group of L6), π-donor hydrogen bond (between residues Thr24, Thr26 and Phe140 and L6) and Van der walls interactions (between the residues Thr25, leu27. His41, Met49, Asn142, Glu160, Gln189 and Thr190 and ligand L6) have also been observed. Six novel azo imidazole derivatives were synthesized in good yields and the products have been characterized by different analytical and spectroscopic tools. Molecular docking study of all the synthesized derivatives have been studied against the main protease (6LU7) of SARS-CoV-2. The docking results attributed various types of protein-ligand interactions and it is also seen that the ligands shows significant interactions at the interface between domain I and domain II except for ligand L2. Furthermore, most of the ligands showed interaction at the Cys145-His41 catalytic dyad. The pharmacokinetic study (ADMET) has revealed that the ligands (L1-L6) could act as a potential drug candidate. Therefore, we may conclude that the ligands (L1-L6) could act as potential inhibitor against the main protease (6LU7) of SARS-CoV-2 and the affinity of ligands (L1-L6) towards the main protease of SARS-CoV-2 follows the order L5> L4≈L6>L1>L2>L3. The authors do not declare any conflict of interest. Table1. Lipinski's properties and pharmacokinetic properties (ADME) of the ligands L1-L6. A novel coronavirus from patients with pneumonia in China Clinical features of patients infected with 2019 novel coronavirus in Epidemiology, genetic recombination, and pathogenesis of coronaviruses Global spread of COVID-19 and pandemic potential Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China COVID-19: Face masks and human-to-human transmission. Influenza Other Respiratory Viruses The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak -an update on the status Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia Therapeutic Development and Drugs for the Treatment of COVID-19 Discovery and development of safe-in-man broad-spectrum antiviral agents an Update on Current Therapeutic Drugs Treating COVID-19 HIV protease inhibitors: a review of molecular selectivity and toxicity Protease inhibitors for the treatment of hepatitis C virus infection Is a Drug Potentially Applicable to the Treatment of Ebola Virus Disease Coronaviruses -drug discovery and therapeutic options Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease tmprss2 Fragment molecular orbital based interaction analyses on COVID-19 main protease-inhibitor N3 complex (PDB ID: 6LU7) Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions Synthesis and evaluation of imidazole-4,5-and pyrazine-2,3-dicarboxamides targeting dengue and yellow fever virus Properties of haloimidazoles Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry Production, isolation and structure elucidation Inamoto FR109615, a new antifungal antibiotic from Streptomyces setonii. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity Jietacins A and B, new nematocidal antibiotics from a streptomyces sp A New Antibiotic, Calvatic Acid Inhibition of viral interferon induction in mammalian cell cultures by azo dyes and derivatives activated with rat liver S9 fraction Imidazothiadiazine dioxides: synthesis and antiviral activity Synthesis and biological activities of Bis alkyl 1, 3, 4-oxadiazole incorporated azo dye derivatives Hou, Design, synthesis and in vitro antibacterial/ antifungal evaluation of novel 1-ethyl-6-fluoro-1, 4-dihydro-4-oxo7 (1-piperazinyl) quinoline-3-carboxylic acid derivatives Complex formation, thermal behavior and stability competition between Cu(II) ion and Cu0 nanoparticles with some new azo dyes. Antioxidant and in vitro cytotoxic activity Synthesis, dyeing performance on polyester fiber and antimicrobial studies of some novel pyrazolotriazine and pyrazolyl pyrazolone azo dyes Binding between the CD4 receptor and polysulfonated azo-dyes. An exploratory theoretical study on action-mechanism1 Synthesis, spectroscopic characterization and in vitro antimicrobial, anticancer and antileishmanial activities as well interaction with Salmon sperm DNA of newly synthesized carboxylic acid derivative, 4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid Synthesis, Spectroscopy, Thermal Analysis, Magnetic Properties and Biological Activity Studies of Cu(II) and Co(II) Complexes with Schiff Base Dye Ligands Synthesis of 2-hydroxy-3-methoxy-5-(4-methoxyphenylazo) benzaldehyde. A new aldehyde for the preparation of biologically active molecules. Molbank, M-37 Pharmacological and Predicted Activities of Natural Azo Compounds Medicinal Importance of Azo and Hippuric Acid Derivatives The first miracle drugs: how the sulfa drugs transformed medicine Oxford Handbook of Infectious Diseases and Microbiology Role of Phenazopyridine in Urinary Tract Infections. Ind Syntheses of Azo-Imine derivatives from vanillin as an acid base indicator Green-synthesized gold nanoparticles decorated graphene sheets for label-free electrochemical impedance DNA hybridization Physico-chemical characterization and biological studies of newly synthesized metal complexes of an Ionic liquid-supported Schiff base: 1-{2 Synthesis, characterization and antibacterial studies of Mn(II) and Co(II) complexes of an ionic liquid tagged Schiff base The Scripps Research Institute Molecular docking: a powerful approach for structure-based drug discovery. Curr. comput-aid drug Molecular Docking Simulation with Special Reference to Flexible Docking Approach Molecular Docking and Structure-Based Drug Design Strategies Study on optimization of molecular structure using Hamiltonian algorithm AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading Pymol: An open-source molecular graphics tool Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro Synthesis, spectral properties, chemical descriptors and light harvesting studies of a new bioactive azo imidazole compound Synthesis of ionic liquid-supported Schiff bases Synthesis, characterization and microbiocidal studies of novel ionic liquid tagged Schiff bases Synthesis, spectral characterizations and antimicrobial activity of some schiff bases of 4-chloro-2-aminophenol The C=N stretching frequency in the infrared spectra of Schiff's base complexes-I. Copper complexes of salicylidene anilines Factors That Influence the C=N Stretching Frequency in Imines Synthesis of New Azo Compounds Based on N-(4-Hydroxypheneyl)maleimide and N-(4-Methylpheneyl)maleimide. Molecules Infrared Spectroscopy of Aqueous Carboxylic Acids: Comparison between Different Acids and Their Salts Abdelaal, 1 H NMR, 13 C NMR and mass spectral studies of some Schiff bases derived from 3-amino-1,2,4-triazole In silico molecular docking and ADME/T analysis of plant compounds against IL17A and IL18 targets in gouty arthritis Chapter 31 -Physiological Aspects Determining the Pharmacokinetic Properties of Drugs. The Practice of Medicinal Chemistry In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin Molecular docking study and antiviral evaluation of 2-thioxo-benzo Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR First Case of 2019 Novel Coronavirus in the United States Molecular Docking and Structure-Based Drug Design Strategies Characterization of Trans-and Cis-Cleavage Activity of the SARS Coronavirus 3CLpro Protease: Basis for the in Vitro Screening of anti-SARS Drugs The authors are grateful to the research facilities available at the St. Joseph's College, Darjeeling and University of North Bengal, Darjeeling. All the authors sincerely acknowledge SAIF, NEHU, Shilong, India for NMR and elemental analysis. Figure S1-S10)